Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-025034
Filing Date
2020-09-14
Accepted
2020-09-14 20:00:14
Documents
2
Period of Report
2020-09-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1522
2 EX-24 DOCUMENT attachment1.htm EX-24 4619
  Complete submission text file 0000899243-20-025034.txt   7632
Mailing Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics, Inc. (Issuer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address
Kaplan Brett (Reporting) CIK: 0001778763 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55939 | Film No.: 201174415